![]() |
|
|
Forward to a colleague |
||
Access Full Stories Geneart has launched the first fully on-line gene construct design and ordering system, dubbed Mr Gene, which is targeting the emerging 'low-price' segment of the synthetic biology market... Read No embryo required: human stem cells from the skin A startling breakthrough has allowed scientists to create human stem cells from just reprogrammed skin cells, with no embryo and thus, perhaps no ethical dilemma... Read Termites suggest route to new biofuel bioreactors The quest for more efficient methods of generating biofuels has been boosted by a metagenomic study of the gut bacteria that enable termites to digest wood... Read Cisbio licenses 'universal' kinase assay platform Cisbio has licensed BellBrook Labs' ADP immunodetection technology for use in its HTRF screening system that will enable researchers to study the activity of any protein kinase... Read Product news in brief - week 47 LabTechnologist.com brings you a round up of the latest product releases, with new offerings from Bio-Rad, KD Scientific, Micronic, Millipore, Q Chip, Thermo Fisher Scientific and Warner Instruments... Read |
||||||||||||||||||
All News Headlines for: November | October | September |
||||||||||||||||||
ZIC®-pHILIC Separation of Polar and Hydrophilic Compounds SeQuant is presenting a new analytical methodology for separation of nucleotides at high pH using gradient elution and ammonium carbonate buffer. Separation is performed on a polymer based ZIC®-pHILIC column and quantification by FTMS - negative ESI-MS detection... Click Here | ||||||||||||||||||
|
Related Industry News New research offers CRO market snapshot New research from Frost & Sullivan provides a snapshot of biopharma spending trends on contract research organisations (CROs), along with forecasts for industry growth... Read Evolution study finds 300 new genes A supercomputer designed to root out genes that have been conserved over millions of years of evolution has discovered 300 new human genes... Read Covance rescues Eli Lilly's forgotten facility Covance has acquired a partially constructed facility from Eli Lilly and plans to invest $175m (€118m) to convert it into a drug development laboratory to meet demand from its biopharmaceutical customers... Read Men get the heads up on possible oral contraceptive It might be years away yet, but men could be the ones popping a pill for contraception if GTx has anything to do with it... Read
|
||||||||||||||||||
|
|||||
Forward to a colleague |
|||||
To continue to receive this newsletter in your inbox, please add newsletter@LabTechnologist.com to your address book |
||
Update preferences | Change your email address | Unsubscribe |
||
Contact us: Advertising | Recruitment | Privacy policy | Terms & conditions | Feedback |
||
| © 2007 - Decision News Media S.A.S - All Rights Reserved Le Belem - 355, rue Vendemiaire - 34000 Montpellier - France http://www.decisionnewsmedia.com |
||